Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Xtant Medical Holdings, Inc. - SIC # 3850 -
Ticker
Exchange
SIC #
Website
Latest Ticker
XTNT
NYSE American
3850
xtantmedical.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Xtant Medical Holdings, Inc.
Xtant Medical Announces the Launch of OsteoFactor Pro™
- May 28th, 2025 6:00 am
Xtant Medical Reports First Quarter 2025 Financial Results
- May 12th, 2025 2:05 pm
Xtant Medical to Issue First Quarter 2025 Financial Results on May 12, 2025
- May 6th, 2025 6:00 am
Xtant Medical Launches Trivium™ Advanced Bone Graft for Superior Performance
- Apr 23rd, 2025 6:00 am
Xtant Medical Announces Secondary Private Sale of Existing Shares by OrbiMed and Preliminary First Quarter 2025 Revenue Growth of 18% to 19%
- Apr 16th, 2025 6:05 am
Xtant Medical Reports Fourth Quarter and Full Year 2024 Financial Results
- Mar 6th, 2025 1:05 pm
Xtant Medical to Issue Fourth Quarter and Year End 2024 Financial Results on March 6, 2025
- Feb 28th, 2025 6:00 am
US Penny Stocks: 3 Picks With Market Caps As Low As $70M
- Feb 20th, 2025 1:11 pm
US Penny Stocks To Watch In January 2025
- Jan 22nd, 2025 1:14 pm
3 US Penny Stocks With Market Caps Under $300M
- Dec 24th, 2024 1:06 pm
Xtant Medical Reports Third Quarter 2024 Financial Results
- Nov 12th, 2024 2:05 pm
Xtant Medical to Attend the 15th Annual Craig-Hallum Alpha Select Conference
- Nov 11th, 2024 6:00 am
Xtant Medical to Issue Third Quarter 2024 Financial Results on November 12, 2024
- Nov 7th, 2024 8:45 am
Xtant Medical Expands Product Portfolio with the Launch of the Cortera(R) Posterior Fixation System
- Sep 23rd, 2024 5:00 am
Xtant Medical Expands Product Portfolio with Launch of its own Viable Bone Matrix, OsteoVive(R) Plus
- Sep 18th, 2024 4:00 am
Xtant Medical Announces $5.0 Million Private Placement
- Aug 8th, 2024 5:20 am
Xtant Medical to Host Second Quarter 2024 Financial Results Earnings Conference call on August 9, 2024
- Aug 8th, 2024 5:10 am
Xtant Medical Reports Second Quarter 2024 Revenue Growth of 48%
- Aug 8th, 2024 5:05 am
Xtant Medical to Present at the Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase
- Jul 25th, 2024 6:30 am
Scroll